Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Immunodeficiency following rituximab therapy: clinical spectrum and monitoring strategies
  1. Home
  2. Publications
  3. Immunodeficiency following rituximab therapy: clinical spectrum and monitoring strategies

Immunodeficiency following rituximab therapy: clinical spectrum and monitoring strategies

Authors:
  • MRMahnaz Rezaei
    Mahnaz Rezaei
  • DSDiba Saeidi
    Diba Saeidi
  • VSVahid Shaygannejad
    Vahid Shaygannejad
  • FAFereshteh Ashtari
    Fereshteh Ashtari
  • SNSomayeh Najafi
    Somayeh Najafi
  • FDFariba Dehghan
    Fariba Dehghan
  • NENarges Ebrahimi
    Narges Ebrahimi
  • FKFarzin Khorvash
    Farzin Khorvash
  • Mazdak Ganjalikhani-Hakemi
    Mazdak Ganjalikhani-Hakemi
  • RSRoya Sherkat
    Roya Sherkat

Open Access
Publisher website
Google Scholar
  • 2 October 2026
    • journal article
    • review article
    • Published by Springer Nature in Clinical and Experimental Medicine
    • DOI:10.1007/s10238-026-02333-x
Abstract
No abstract available
Keywords
  • RITUXIMAB
  • MONOCLONAL ANTIBODY
  • CD20
  • HYPOGAMMAGLOBULINEMIA
  • IMMUNODEFICIENCY
  • B-CELL
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.